Previous Next

2024-03-04

Drug treatment or bariatric surgery for type 2 diabetes ?

Endocrinology and Metabolism

In this pooled analysis of four U.S. clinical trials conducted between 2007 and 2013, researchers evaluated the long-term glycemic control and safety of bariatric surgery (Roux-en-Y gastric bypass, sleeve gastrectomy, adjustable gastric banding) compared with lifestyle measures coupled with drug therapy for type 2 diabetes. A total of 262 patients were followed for 7 to 12 years. At the end of this follow-up, patients who had undergone bariatric surgery had better glycemic control, less use of antidiabetic drugs and a higher rate of diabetes control, compared with patients who had benefited from hygienic-dietary measures coupled with medication.

Source(s) :
Anita P Courcoulas et al. Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes. JAMA. 2024 Feb 27;331(8):654-664. ;

Last press reviews


COVID-19 and coagulation parameters: a link to mortality?

The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths...

Resistance training and Multiple Sclerosis: a solution to improve function and quality of life?

Multiple sclerosis (MS) is a chronic autoimmune disease of the central ner...

Endometriosis: the Impact of hormones, sexual practice, and surgical treatments

Endometriosis is a chronic inflammatory disease modulated by estrogen leve...